Multicentric validation of diagnostic tests based on BC-116 and BC-106 urine peptide biomarkers for bladder cancer in two prospective cohorts of patients.

Saved in:
Bibliographic Details
Title: Multicentric validation of diagnostic tests based on BC-116 and BC-106 urine peptide biomarkers for bladder cancer in two prospective cohorts of patients.
Authors: Mengual, Lourdes1,2 (AUTHOR), Frantzi, Maria3 (AUTHOR) frantzi@mosaiques-diagnostics.com, Mokou, Marika3 (AUTHOR), Ingelmo-Torres, Mercedes1 (AUTHOR), Vlaming, Michiel4 (AUTHOR), Merseburger, Axel S.5 (AUTHOR), Roesch, Marie C.5 (AUTHOR), Culig, Zoran6 (AUTHOR), Alcaraz, Antonio1 (AUTHOR), Vlahou, Antonia7 (AUTHOR), Mischak, Harald3,8 (AUTHOR), Van der Heijden, Antoine G.4 (AUTHOR)
Source: British Journal of Cancer. Nov2022, Vol. 127 Issue 11, p2043-2051. 9p.
Database: Academic Search Ultimate
Description
ISSN:00070920
DOI:10.1038/s41416-022-01992-3